Global 24 hour Ambulatory Blood Pressure Monitoring Device Market Size By Type (Ordinary ABPM, Mobile-based ABPM), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global 24-Hour Ambulatory Blood Pressure Monitoring (ABPM) Device Market was valued at USD 2.1 billion in 2023 and is expected to reach USD 4.2 billion by 2031, growing at a CAGR of 9.1% during the forecast period from 2023 to 2031. The market is driven by the growing prevalence of hypertension and cardiovascular diseases, increasing awareness regarding preventive healthcare, and the rising demand for non-invasive and continuous blood pressure monitoring technologies. As healthcare systems shift toward outpatient and home-based care, 24-hour ABPM devices are becoming critical tools in both clinical and remote settings for accurate diagnosis and monitoring.

Drivers:

1. Growing Incidence of Hypertension and Cardiovascular Disorders:

The global rise in hypertension cases, particularly among aging populations, is one of the primary drivers for ABPM devices. These devices provide more accurate blood pressure readings over 24 hours, minimizing white-coat and masked hypertension effects.

2. Shift Toward Preventive and Home Healthcare:

As healthcare costs rise, there is a significant shift towards preventive care and remote monitoring solutions. ABPM devices offer convenient and reliable options for continuous monitoring, supporting early diagnosis and better disease management.

3. Technological Advancements:

Innovations in wearable sensor technology, wireless connectivity, and cloud integration have made ABPM devices more user-friendly and precise. These advancements enhance patient compliance and clinician access to real-time data.

Restraints:

1. High Cost and Limited Reimbursement Policies:

The relatively high cost of ABPM devices and the lack of comprehensive reimbursement coverage in many countries may limit adoption, especially in low- and middle-income regions.

2. Patient Discomfort and Compliance Issues:

Some users experience discomfort wearing the device for 24 hours, which may affect adherence and the quality of readings.

Opportunity:

1. Expansion in Emerging Economies:

Rapid urbanization, lifestyle changes, and growing awareness about hypertension in emerging markets like Asia-Pacific and Latin America are creating new opportunities for ABPM device manufacturers.

2. Integration with AI and Digital Health Platforms:

The integration of ABPM data with AI-driven analytics and telemedicine platforms opens up new possibilities for personalized and predictive healthcare, driving market growth.

Market by System Type Insights:

By system type, Wrist ABPM Devices held the largest market share in 2023 due to their convenience, portability, and high patient compliance. However, Upper Arm ABPM Devices are anticipated to grow significantly during the forecast period owing to their higher accuracy and preference in clinical environments. The increasing availability of Bluetooth-enabled devices with real-time reporting is boosting demand across both segments.

Market by End-Use Insights:

The Hospitals and Clinics segment dominated the market in 2023, driven by routine use of ABPM devices for in-depth cardiovascular assessments. The Homecare Settings segment is projected to exhibit the fastest growth due to the surge in remote monitoring and self-management trends, particularly among elderly and chronically ill patients.

Market by Regional Insights:

North America led the market in 2023, attributed to the region's advanced healthcare infrastructure, high prevalence of hypertension, and strong reimbursement frameworks. Asia-Pacific is projected to experience the highest CAGR during the forecast period, supported by rising healthcare investments, growing awareness, and an increasing geriatric population in countries like China and India.

Competitive Scenario:

Key players in the Global 24-Hour ABPM Device Market include Spacelabs Healthcare, Welch Allyn (Hill-Rom), Schiller AG, Microlife Corporation, Contec Medical Systems, BPL Medical Technologies, Withings, and SunTech Medical. These companies are focusing on developing compact, wearable, and AI-integrated ABPM solutions. Strategic alliances and product launches are central to their expansion strategies.

Scope of Work – Global 24-Hour Ambulatory Blood Pressure Monitoring Device Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 4.2 billion

CAGR (2023–2031) 9.1%

Market Segments System Type (Wrist, Upper Arm), End-use, Region

Growth Drivers Hypertension prevalence, shift to home care, tech integration

Opportunities Emerging markets, AI & digital health platforms

Key Market Developments:

2023: Spacelabs Healthcare launched a cloud-connected ABPM device integrated with real-time analytics for remote diagnosis.

2024: Welch Allyn (Hill-Rom) introduced a new ABPM monitor with extended battery life and advanced data encryption.

2025: Microlife Corporation partnered with a leading telemedicine provider to integrate ABPM readings into virtual care platforms.

FAQs:

1) What is the current market size of the Global 24-Hour Ambulatory Blood Pressure Monitoring Device Market?

The market was valued at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global 24-Hour Ambulatory Blood Pressure Monitoring Device Market?

The primary driver is the growing prevalence of hypertension and the increasing demand for accurate, 24-hour monitoring solutions.

3) Which is the largest region during the forecast period in the Global 24-Hour Ambulatory Blood Pressure Monitoring Device Market?

North America is the largest region due to advanced healthcare infrastructure and high disease prevalence.

4) Which segment accounted for the largest market share in the Global 24-Hour Ambulatory Blood Pressure Monitoring Device Market?

Wrist ABPM Devices held the largest market share in 2023 due to their ease of use and higher compliance.

5) Who are the key market players in the Global 24-Hour Ambulatory Blood Pressure Monitoring Device Market?

Key players include Spacelabs Healthcare, Welch Allyn, Schiller AG, Microlife Corporation, and SunTech Medical.